These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306 [TBL] [Abstract][Full Text] [Related]
3. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients. Waldhäusl WK; Bratusch-Marrain PR; Francesconi M; Nowotny P; Kiss A Diabetes Care; 1982; 5(1):18-24. PubMed ID: 6754299 [TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654 [TBL] [Abstract][Full Text] [Related]
5. The absorption kinetics of subcutaneously infused U 40 and U 100 insulin in diabetics. Wahab PJ; Rijnsburger AW; van der Veen EA; Heine RJ Diabetes Res Clin Pract; 1987; 3(4):203-6. PubMed ID: 3304907 [TBL] [Abstract][Full Text] [Related]
6. Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection. Murat A; Slama G Metabolism; 1985 Feb; 34(2):120-3. PubMed ID: 3881645 [TBL] [Abstract][Full Text] [Related]
7. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin. de Meijer PH; Lutterman JA; van't Laar A Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571 [TBL] [Abstract][Full Text] [Related]
8. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites. Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016 [TBL] [Abstract][Full Text] [Related]
9. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
10. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. Polonsky KS; Given BD; Van Cauter E J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730 [TBL] [Abstract][Full Text] [Related]
11. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. SaccĂ L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
14. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747 [TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Pickup JC; Keen H; Parsons JA; Alberti KG Br Med J; 1978 Jan; 1(6107):204-7. PubMed ID: 340000 [TBL] [Abstract][Full Text] [Related]
16. Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate. Chisholm DJ; Kraegen EW; Hewett MJ; Furler S Diabetologia; 1984 Aug; 27(2):238-41. PubMed ID: 6386586 [TBL] [Abstract][Full Text] [Related]
17. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887 [TBL] [Abstract][Full Text] [Related]
18. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [TBL] [Abstract][Full Text] [Related]
19. Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies. Kraegen EW; Chisholm DJ Diabetologia; 1984 Mar; 26(3):208-13. PubMed ID: 6370771 [TBL] [Abstract][Full Text] [Related]
20. Insulin oscillations per se do not affect glucose turnover parameters in normal man. Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]